Target intelligence / Profile preview

Glucose transporters and extracellular matrix proteins on corneal epithelium

Molecular classification
Transporter, Other
01

Overview

The corneal epithelium relies on a specific suite of glucose transporters (GLUTs) and extracellular matrix (ECM) proteins to maintain transparency and structural integrity. GLUT1 is the predominant transporter facilitating glucose uptake from the aqueous humor to support the high metabolic activity of the epithelial layer (Takahashi et al., 1996, PMID: 8922143). The ECM, composed of proteins such as collagen type IV, laminin, and fibronectin, forms the basement membrane and provides the scaffold for epithelial cell adhesion and migration (Ljubimov & Saghizadeh, 2015, PMID: 25703250). In conditions like diabetic keratopathy, hyperglycemia leads to the downregulation of GLUTs and the thickening of the basement membrane through excessive ECM deposition, which impairs wound healing and nerve function (Kaji, 2005, PMID: 15851931). While not a single therapeutic target, this system is a focus for ocular drug delivery research, where GLUTs are exploited to transport prodrugs across the corneal barrier (Vooturi et al., 2012, PMID: 22403145). Modulating ECM components also represents a strategy for treating persistent corneal epithelial defects and scarring.

Other names
Corneal epithelial glucose transportersCorneal extracellular matrixGLUTs and ECM in corneaCorneal epithelial transport system
02

Mechanism of action

Facilitated diffusion of glucose via GLUT transporters and structural support/signaling via extracellular matrix protein interactions.

03

Biological functions

Glucose transportCell adhesionTissue remodelingWound healingMetabolic homeostasis
04

Disease associations

Diabetic keratopathyCorneal dystrophyCorneal wound healingDry eye syndrome
05

Safety considerations

Potential for systemic glucose dysregulation if transporters are targeted non-specificallyRisk of corneal scarring or impaired transparency when modulating ECM proteinsDelayed epithelial wound healing
06

Interacting drugs

Insulin

3 more in the full profile.

07

Biomarkers

GLUT1 expressionCollagen IV levelsFibronectin expressionLaminin-5

Beyond the preview

Go deeper on Glucose transporters and extracellular matrix proteins on corneal epithelium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucose transporters and extracellular matrix proteins on corneal epithelium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call